Data / Drug companies / Injection, powder, lyophilized, for solution
Companies that list injection, powder, lyophilized, for solution products: 225 companies and 1,147 products in the FDA NDC directory
The FDA National Drug Code Directory lists 1,147 products that are injection, powder, lyophilized, for solution products from 225 companies. The ten largest listers hold 40.9% of them, and the newest started marketing on October 22, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 225
- Products
- 1,147
- Drugs by generic name
- 225
- Main marketing category
- Generic drugs (ANDA)
Companies that list injection, powder, lyophilized, for solution products
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Fresenius Kabi USA, LLC | 99 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 1, 2023 |
| Hikma Pharmaceuticals USA Inc. | 55 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 22, 2026 |
| Meitheal Pharmaceuticals Inc. | 49 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 1, 2026 |
| Eugia US LLC | 47 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 30, 2023 |
| Sagent Pharmaceuticals | 46 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 15, 2026 |
| Gland Pharma Limited | 44 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 14, 2026 |
| Patheon Italia S.p.A. | 41 | injection, powder, lyophilized, for solution | Drugs for further processing | September 2, 2026 |
| BluePoint Laboratories | 32 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 29, 2026 |
| Hospira, Inc. | 30 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 27, 2022 |
| Mylan Institutional LLC | 26 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 25, 2024 |
| Dr. Reddy's Laboratories Inc. | 19 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | February 12, 2026 |
| Jubilant HollisterStier LLC | 16 | injection, powder, lyophilized, for solution | Biologics (BLA) | May 22, 2026 |
| Accord Healthcare Inc. | 14 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 7, 2022 |
| Ascendis Pharma Endocrinology, Inc. | 14 | injection, powder, lyophilized, for solution | Biologics (BLA) | July 25, 2025 |
| Patheon Manufacturing Services LLC | 14 | injection, powder, lyophilized, for solution | Drugs for further processing | August 2, 2022 |
| Slate Run Pharmaceuticals, LLC | 14 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 27, 2024 |
| Fosun Pharma USA Inc. | 13 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 16, 2025 |
| BSP Pharmaceuticals S.p.A. | 12 | injection, powder, lyophilized, for solution | Drugs for further processing | May 29, 2026 |
| Camber Pharmaceuticals, Inc. | 12 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 5, 2025 |
| Genzyme Corporation | 12 | injection, powder, lyophilized, for solution | Biologics (BLA) | August 29, 2022 |
| Sandoz Inc | 12 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 16, 2024 |
| Apotex Corp. | 11 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 30, 2026 |
| Fresenius Kabi USA, LLC | 11 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 1, 2024 |
| Glenmark Pharmaceuticals Inc., USA | 11 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 12, 2026 |
| Amneal Pharmaceuticals LLC | 10 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 18, 2025 |
| Civica, Inc. | 10 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 28, 2025 |
| Novadoz Pharmaceuticals LLC | 10 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | March 26, 2025 |
| Par Health USA, LLC | 10 | injection, powder, lyophilized, for solution | New drug applications (NDA) | October 27, 2025 |
| Qilu Pharmaceutical Co., Ltd. | 10 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 3, 2025 |
| XGen Pharmaceuticals DJB, Inc. | 10 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 15, 2025 |
| Bamboo US Bidco LCC | 8 | injection, powder, lyophilized, for solution | Drugs for further processing | October 8, 2026 |
| NorthStar RxLLC | 8 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 1, 2024 |
| Xellia Pharmaceuticals USA LLC | 8 | injection, powder, lyophilized, for solution | New drug applications (NDA) | November 3, 2023 |
| Amgen, Inc | 6 | injection, powder, lyophilized, for solution | Biologics (BLA) | December 12, 2019 |
| Genentech, Inc. | 6 | injection, powder, lyophilized, for solution | Biologics (BLA) | June 10, 2019 |
| Mylan Institutional LLC | 6 | injection, powder, lyophilized, for solution | New drug applications (NDA) | September 1, 2026 |
| Pfizer Laboratories Div Pfizer Inc | 6 | injection, powder, lyophilized, for solution | Biologics (BLA) | July 30, 2024 |
| Roerig | 6 | injection, powder, lyophilized, for solution | New drug applications (NDA) | February 20, 2024 |
| Zydus Lifesciences Limited | 6 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 1, 2024 |
| Zydus Pharmaceuticals USA Inc. | 6 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 1, 2024 |
| Avenacy, LLC | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 30, 2026 |
| Avyxa Pharma, LLC | 5 | injection, powder, lyophilized, for solution | New drug applications (NDA) | July 23, 2026 |
| HF Acquisition Co LLC, DBA HealthFirst | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 31, 2022 |
| Maia Pharmaceuticals, Inc. | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 8, 2025 |
| Merz Pharmaceuticals, LLC | 5 | injection, powder, lyophilized, for solution | Biologics (BLA) | November 20, 2015 |
| NorthStar Rx LLC | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 28, 2023 |
| Pfizer Manufacturing Belgium NV | 5 | injection, powder, lyophilized, for solution | Drugs for further processing | July 31, 2014 |
| Pharmacia & Upjohn Company LLC | 5 | injection, powder, lyophilized, for solution | New drug applications (NDA) | May 1, 2012 |
| Provepharm Inc. | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 11, 2023 |
| Somerset Therapeutics, LLC | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 27, 2026 |
| Steriscience Specialties Private Limited | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 10, 2026 |
| Tianjin Kingyork Pharmaceuticals Co., Ltd | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 20, 2021 |
| Accord BioPharma Inc. | 4 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 1, 2025 |
| Allergan, Inc. | 4 | injection, powder, lyophilized, for solution | Biologics (BLA) | January 11, 2010 |
| Archis Pharma LLC | 4 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 25, 2022 |
| Armas Pharmaceuticals Inc. | 4 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 21, 2026 |
| Be Pharmaceuticals Inc. | 4 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 12, 2026 |
| Curium US LLC | 4 | injection, powder, lyophilized, for solution | New drug applications (NDA) | April 8, 2025 |
| E.r. Squibb & Sons, L.L.C. | 4 | injection, powder, lyophilized, for solution | Biologics (BLA) | November 30, 2015 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 4 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 15, 2022 |
| Lsne, Inc. | 4 | injection, powder, lyophilized, for solution | Drugs for further processing | December 13, 2024 |
| Melinta Therapeutics, LLC | 4 | injection, powder, lyophilized, for solution | New drug applications (NDA) | June 9, 2023 |
| Merck Sharp & Dohme LLC | 4 | injection, powder, lyophilized, for solution | New drug applications (NDA) | February 3, 2017 |
| Onesource Specialty Pharma Limited | 4 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 27, 2026 |
| Wyeth Pharmaceuticals LLC, a Subsidiary of Pfizer Inc. | 4 | injection, powder, lyophilized, for solution | Biologics (BLA) | September 7, 2017 |
| AbbVie Inc. | 3 | injection, powder, lyophilized, for solution | Biologics (BLA) | May 27, 2026 |
| Acrotech Biopharma Inc | 3 | injection, powder, lyophilized, for solution | New drug applications (NDA) | January 2, 2019 |
| BTG International Inc. | 3 | injection, powder, lyophilized, for solution | Biologics (BLA) | December 15, 2021 |
| Biocon Pharma Inc. | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 1, 2025 |
| Bryant Ranch Prepack | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | March 11, 2022 |
| Celgene Corporation | 3 | injection, powder, lyophilized, for solution | Biologics (BLA) | November 8, 2019 |
| Celltrion, Inc | 3 | injection, powder, lyophilized, for solution | Drugs for further processing | November 21, 2016 |
| Cephalon, LLC | 3 | injection, powder, lyophilized, for solution | New drug applications (NDA) | March 16, 2020 |
| Chiesi USA, Inc. | 3 | injection, powder, lyophilized, for solution | Biologics (BLA) | March 1, 2023 |
| Dr. Reddy's Laboratories Limited | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 11, 2013 |
| Endo USA, Inc. | 3 | injection, powder, lyophilized, for solution | New drug applications (NDA) | April 15, 2012 |
| Henry Schein, Inc. | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 11, 2022 |
| Jubilant DraxImage Inc., DBA Jubilant Radiopharma | 3 | injection, powder, lyophilized, for solution | New drug applications (NDA) | March 31, 2023 |
| Lyocontract GmbH | 3 | injection, powder, lyophilized, for solution | Drugs for further processing | April 15, 2026 |
| Medi-Physics Inc. DBA GE Healthcare | 3 | injection, powder, lyophilized, for solution | New drug applications (NDA) | February 26, 2009 |
| Merz North America, Inc. | 3 | injection, powder, lyophilized, for solution | Biologics (BLA) | August 1, 2011 |
| Mitim S.r.l. | 3 | injection, powder, lyophilized, for solution | Drugs for further processing | March 22, 2017 |
| Novartis Pharmaceuticals Corporation | 3 | injection, powder, lyophilized, for solution | New drug applications (NDA) | March 23, 2022 |
| Onyx Pharmaceuticals, Inc. | 3 | injection, powder, lyophilized, for solution | New drug applications (NDA) | May 23, 2018 |
| Samson Medical Technologies LLC | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 1, 2016 |
| Samsung Biologics Co., Ltd. | 3 | injection, powder, lyophilized, for solution | Drugs for further processing | July 8, 2023 |
| Seagen Inc. | 3 | injection, powder, lyophilized, for solution | Biologics (BLA) | December 18, 2019 |
| Sun Pharmaceutical Industries, Inc. | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 2, 2019 |
| Sun Pharmaceutical Industries, Inc. | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 16, 2021 |
| Waverley Pharma Inc | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 19, 2018 |
| Actavis Pharma, Inc. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 5, 2015 |
| Actelion Pharmaceuticals US, Inc. | 2 | injection, powder, lyophilized, for solution | New drug applications (NDA) | April 22, 2010 |
| Almaject, Inc. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 1, 2022 |
| American Regent, Inc. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 1, 2015 |
| Athenex Pharmaceutical Division, LLC. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 30, 2019 |
| Baxter Healthcare Corporation | 2 | injection, powder, lyophilized, for solution | New drug applications (NDA) | January 25, 2022 |
| Biocon Biologics Inc. | 2 | injection, powder, lyophilized, for solution | Biologics (BLA) | October 1, 2023 |
| Bracco Diagnostics Inc | 2 | injection, powder, lyophilized, for solution | New drug applications (NDA) | January 21, 1987 |
| Bristol-Myers Squibb Company | 2 | injection, powder, lyophilized, for solution | Bulk ingredients | November 10, 2016 |
| Cardinal Health 414, LLC | 2 | injection, powder, lyophilized, for solution | New drug applications (NDA) | December 1, 2020 |
Drugs most often listed
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.